位置:成果数据库 > 期刊 > 期刊详情页
去泛素化酶在皮肤病的研究进展
  • 期刊名称:国际皮肤性病学杂志
  • 时间:2013.11.15
  • 页码:380-383
  • 分类:R362[医药卫生—病理学;医药卫生—基础医学]
  • 作者机构:[1]华中科技大学同济医学院附属协和医院皮肤科,武汉430022
  • 相关基金:国家自然科学基金(81101191)
  • 相关项目:阻断mTOR通路诱导Foxp3表达在银屑病发病中的作用机制
作者: shan juan chen|
中文摘要:

去泛素化酶家族种类繁多,分布于人体多种器官及组织,是泛素-蛋白酶体途径的重要组成部分,精细调控真核细胞生物细胞内蛋白的降解。A20、CYLD、泛素特异性加工酶7等去泛素化酶通过与外异蛋白受体、Fas相关的死亡区蛋白、B细胞淋巴因子-3、核因子-KB抑制蛋白激酶等因子相互作用,可参与银屑病、皮肤基底细胞癌、皮肤鳞状细胞癌、皮肤附属器肿瘤、Kaposi肉瘤以及恶性黑素瘤等皮肤疾病的发生发展。探讨去泛素化酶作用机制,有助于为炎症及肿瘤性皮肤病提供新的治疗靶点。

英文摘要:

There are a great variety of deubiquitinating enzymes (DUBs) distributed in multiple human tis sues and organs. As an important part of ubiquitin-proteasome pathway (UPP), DUBs can tightly control the degra dation of eukaryotic intracellular proteins. It has been revealed that some deubiquitinating enzymes such as A20, cylindromatosis (CYLD) and ubiquitin-speeific processing protease-7 (USP7) may take part in the occurrence and development of psoriasis, basal cell carcinoma, squamous cell carcinoma, cutaneous adnexal neoplasms, Kaposis sarcoma and malignant melanoma through interaction with ectodysplasin-A receptor (EDAR), Fas-assoeiated death domain-containing protein (FADD), B-cell leukemia/lymphoma 3 (Bcl-3), I kappa B kinase (IKK), and so on. Therefore, exploring the action mechanism of deubiquitinating enzymes will help to find new targets for the treat ment of inflammatory dermatoses and skin tumors.

同期刊论文项目
同项目期刊论文